Literature DB >> 22749997

Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.

Kathryn J Huber-Keener1, Brad R Evans, Xingcong Ren, Yan Cheng, Yi Zhang, William N Hait, Jin-Ming Yang.   

Abstract

Eukaryotic elongation factor-2 kinase (eEF-2K) is a Ca(2+)/calmodulin-dependent enzyme that negatively regulates protein synthesis. eEF-2K has been shown to be up-regulated in cancer, and to play an important role in cell survival through inhibition of protein synthesis. Post-translational modification of protein synthesis machinery is important for its regulation and could be critical for survival of cancer cells encountering stress. The purpose of our study was to examine the regulation of eEF-2K during stress with a focus on the roles of phosphorylation in determining the stability of eEF-2K. We found that stress conditions (nutrient deprivation and hypoxia) increase eEF-2K protein. mRNA levels are only transiently increased and shortly return to normal, while eEF-2K protein levels continue to increase after further exposure to stress. A seemingly paradoxical decrease in eEF-2K stability was found when glioma cells were subjected to stress despite increased protein expression. We further demonstrated that phosphorylation of eEF-2K differentially affects the enzyme's turnover under both normal and stress conditions, as evidenced by the different half-lives of phosphorylation-defective mutants of eEF-2K. We further found that the eEF-2K site (Ser398) phosphorylated by AMPK is pivotal to the protein's stability, as the half-life of S398A mutant increases to greater than 24h under both normal and stress conditions. These data indicate that eEF-2K is regulated at multiple levels with phosphorylation playing a critical role in the enzyme's turnover under stressful conditions. The complexity of eEF-2K phosphorylation highlights the intricacies of protein synthesis control during cellular stress.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749997      PMCID: PMC3614095          DOI: 10.1016/j.bbrc.2012.06.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Management of cellular energy by the AMP-activated protein kinase system.

Authors:  D Grahame Hardie; John W Scott; David A Pan; Emma R Hudson
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

2.  Global mRNA stabilization preferentially linked to translational repression during the endoplasmic reticulum stress response.

Authors:  Tomoko Kawai; Jinshui Fan; Krystyna Mazan-Mamczarz; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

3.  NMDA receptor-mediated control of protein synthesis at developing synapses.

Authors:  A J Scheetz; A C Nairn; M Constantine-Paton
Journal:  Nat Neurosci       Date:  2000-03       Impact factor: 24.884

4.  Nerve growth factor-induced down-regulation of calmodulin-dependent protein kinase III in PC12 cells involves cyclic AMP-dependent protein kinase.

Authors:  M J Brady; A C Nairn; J A Wagner; H C Palfrey
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

5.  Inhibition of the phosphorylation of a 1000,000-dalton soluble protein in whole cells and cell-free extracts of PC12 pheochromocytoma cells following treatment with nerve growth factor.

Authors:  D End; M Hanson; S Hashimoto; G Guroff
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

6.  Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity.

Authors:  T A Diggle; T Subkhankulova; K S Lilley; N Shikotra; A E Willis; N T Redpath
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

7.  Increased phosphorylation of elongation factor 2 during mitosis in transformed human amnion cells correlates with a decreased rate of protein synthesis.

Authors:  J E Celis; P Madsen; A G Ryazanov
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation.

Authors:  A G Ryazanov; E K Davydova
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

9.  Rapid activation of calmodulin-dependent protein kinase III in mitogen-stimulated human fibroblasts. Correlation with intracellular Ca2+ transients.

Authors:  H C Palfrey; A C Nairn; L L Muldoon; M L Villereal
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

10.  Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2.

Authors:  A C Nairn; H C Palfrey
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

View more
  1 in total

1.  Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour Development.

Authors:  Saketh S Dinavahi; Yu-Chi Chen; Raghavendra Gowda; Pavan Kumar Dhanyamraju; Kishore Punnath; Dhimant Desai; Arthur Berg; Scot R Kimball; Shantu Amin; Jin-Ming Yang; Gavin P Robertson
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.